Pentagon showdown for vaccine

By Kris Herbst
Contributing Editor

WASHINGTON - The controversy over the Army's plan to test MicroGeneSys Inc.'s gp160 therapeutic AIDS vaccine in an exclusive, large-scale Phase III trial may be resolved finally at a meeting to be convened at the Pentagon Tuesday by Defense Secretary Les Aspin, according to a Washington representative for the company.